vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.02M | 1.00M | 1.00M | 1.00M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.02M | 1.00M | 1.00M | 1.00M | -- |
| Cost of Revenue | -988.00K | 8.23M | 7.83M | 7.72M | 9.01M |
| Gross Profit | 2.02M | -7.23M | -6.83M | -6.72M | -9.01M |
| SG&A Expenses | 13.65M | 13.55M | 12.81M | 12.40M | 11.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.20M | 25.00M | 23.86M | 24.70M | 25.50M |
| Operating Income | -24.18M | -24.00M | -22.86M | -23.70M | -25.50M |
| Income Before Tax | -22.61M | -22.61M | -25.31M | -26.11M | -25.97M |
| Income Tax Expenses | 100.00K | 100.00K | 100.00K | 100.00K | -- |
| Earnings from Continuing Operations | -22.71 | -22.71 | -25.41 | -26.21 | -25.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.24M | 4.40M | 5.23M | 5.60M | 5.72M |
| Net Income | -18.46M | -18.31M | -20.18M | -20.62M | -20.25M |
| EBIT | -24.18M | -24.00M | -22.86M | -23.70M | -25.50M |
| EBITDA | -24.09M | -23.91M | -22.77M | -23.61M | -25.41M |
| EPS Basic | -4.24 | -5.35 | -7.67 | -9.55 | -9.71 |
| Normalized Basic EPS | -2.25 | -2.83 | -4.01 | -4.97 | -5.58 |
| EPS Diluted | -4.24 | -5.35 | -7.67 | -9.55 | -9.71 |
| Normalized Diluted EPS | -2.25 | -2.83 | -4.01 | -4.97 | -5.58 |
| Average Basic Shares Outstanding | 20.88M | 16.38M | 13.01M | 8.69M | 8.34M |
| Average Diluted Shares Outstanding | 20.88M | 16.38M | 13.01M | 8.69M | 8.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |